novartis india ltd
(500672:Bombay Stock Exchange)

Executive Profile*

Background*

Dr. Daniel L. Vasella, MD, Dan, has been Chief Executive Officer of Novartis International AG since 1996. Dr. Vasella served as Chief Executive Officer of Novartis Consumer Health, Inc. since 1996. He served as the Chief Executive Officer of Novartis AG. from 1996 to February 1, 2010. He served as Chief Executive Officer of Novartis Vaccines & Diagnostics, Inc. since 1996 and served as its Chairman since 1996. He served as the President at Novartis AG since 1996. From ... 1992 to 1996, Dr. Vasella served as Chief Executive Officer, Chief Operating Officer, Senior Vice President and Head of Worldwide Development, and Head of Corporate Marketing and Chief Executive Officer at Sandoz Pharma Ltd. In this capacity, he was responsible for managing all activities of the pharmaceuticals division of the Sandoz Group worldwide. From 1988 to 1992, Dr. Vasella was employed at Sandoz Pharmaceuticals Corp. as Director and Department Head in Marketing. He held a number of medical positions in Switzerland. He served as President of The International Federation of Pharmaceutical Manufacturers & Associations. He has been Chairman of Novartis Consumer Health, Inc. since 1999. He serves as Chairman of Novartis Corporation. He has been Chairman of Alcon, Inc. since October 24, 2010 and has been its Director since July 2008. He served as Chairman of Novartis International AG until February 2013 and Novartis AG since April 1999. He has been a Director of Novartis Consumer Health, Inc. since 1996 and Pepsico, Inc. since February 2002. Dr. Vasella serves on several Sandoz Boards and also on the Board of Genetic Therapy Inc. He serves as a Member of the Advisory Board at KBL Healthcare Ventures, the International Board of Governors of the Peres Center of Peace in Israel, and a Member of several industry associations and educational institutions. He has been a Director for American Express Company since July 19, 2012. He has been Executive Director of Novartis AG since 1996. He serves as Member of Governing Board at Indian School of Business. Dr. Vasella serves as a Member of the Board of Directors of Associates of Harvard Business School, and IMD. He was a Member of the Boards of INSEAD. He served as Director of Novartis Vaccines & Diagnostics, Inc. since 1996. He served as Director of Credit Suisse Group. He served as a Director of SyStemix, Inc. since June 1995. He served as a Member of the Supervisory Board of Siemens Aktiengesellschaft (Siemens AG) until January 23, 2003. He served as a Director of AXA Versicherungen AG (also known as Winterthur Swiss Insurance) until April 25, 2003. He serves as the Vice Chairman of the International Business Leaders Advisory Council for the Mayor of Shanghai. He serves as a Member of the Chairman's Council of DaimlerChrysler AG, Germany. After holding a number of medical positions in Switzerland in 2002, Dr. Vasella was awarded an honorary doctorate by the University of Basel. He has been honored with the Ordem Nacional do Cruzeiro do Sul (Brazil) and holds the rank of Chevalier in the Ordre National de la Légion d'Honneur (France). He holds an M.D. degree in Medicine from the University of Berne in 1979. He completed executive training at the Harvard Business School in the United States.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
HCBA:IN	499.90 INR	-2.90

COMPETITOR COMPENSATION